Prognostic value of serial B-type natriuretic peptide testing during follow-up of patients with unstable coronary artery disease

Article Abstract:

A study to determine whether concentrations of B-type natriuretic peptide (BNP) at study entry and at outpatient follow-up at 4 months and 12 months are associated with subsequent clinical outcomes is presented. Serial determinations of BNP levels during outpatient follow-up after acute coronary syndrome (ACS) predict the risk of death or new congestive heart failure (CHF).

Health aspects, Patient outcomes, Risk factors, Natriuretic peptides

---

High-risk patients with acute coronary syndromes treated with low-molecular-weight or unfractionated heparin

Article Abstract:

A SYNERGY trial study was conducted to evaluate continued risk in patients with acute coronary syndromes (ACS) through 6-months and 1-year follow-up. A comparison of enoxaparin and unfractionated heparin in these patients showed that enoxaparin was not inferior to unfractionated heparin in reducing death or nonfatal myocardial infraction (MI) at 30 days.

Pharmaceutical Preparation Manufacturing, Pharmaceutical preparations, Heparin Preparations, Care and treatment, Usage, Heparin, Enoxaparin

---

Similar abstracts:

• Abstracts: N-Terminal pro-brain natriuretic peptide levels and risk of death in sickle cell disease. Dysregulated arginine metabolism, hemolysis-associated pulmonary hypertension, and mortality in sickle cell disease
• Abstracts: The role of maternal body mass index in outcomes of vaginal births after cesarean. Trial of labor in patients with a previous cesarean section: does maternal age influence the outcome?
• Abstracts: Enoxaparin vs. unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndromes managed with an intended early invasive strategy

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.